Lehrstuhl für Biochemie und Molekulare Medizin


close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
Exploring Brain Mechanics (EBM): Understanding, engineering and exploiting mechanical properties and signals in central nervous system development, physiology and pathology (SFB 1540 - EBM) Jan. 1, 2023 - Dec. 31, 2026 D042: Role of prosaposin (PSAP) in liver steatosis-triggered hepatocellular carcinoma April 1, 2023 - Sept. 30, 2025 D038: Impact of the transcriptional regulator AP2e on melanoma development and progression March 16, 2023 - Sept. 15, 2025 P110: Analysis of the molecular function of MAGOH in melanoma cells and its impact on cell viability March 1, 2024 - Dec. 31, 2024 D031 (Biochemie u. Mol. Medizin: Modulation of oncogene-induced senescence by cell-matrix adhesion March 16, 2020 - March 15, 2023 Ultrasensitive marker-free biomolecular THz-detection for tumor related analytics: PCR-free sensitivity, biomolecular extension and biological relevance (ESSENCE) SPP 1857: Elektromagnetische Sensoren für Life Sciences (ESSENCE) Jan. 1, 2015 - Sept. 30, 2022 P082: Physiological Stress in Safer Cycling in Older Age– Effect of an Exercise Intervention: SiFAr-Stress Sept. 1, 2021 - Aug. 31, 2022 A5 CYLD-ein möglicher Mediator der Gewebe-spezifischen Melanommetastasierung Teilprojekt TP A5 CYLD-ein möglicher Mediator der Gewebe-spezifischen Melanommetastasierung July 1, 2018 - June 30, 2021 MIA-X - M4-Award Biotechnologie (MIA-X) Jan. 1, 2017 - Feb. 28, 2021 P033 (Biochemie, Mol. Medizin): The role of the transcription factor YB-1 in molecular regulation of chondrogenesis March 26, 2019 - March 25, 2020